238 related articles for article (PubMed ID: 11889405)
41. Immunohistochemical characterization of p57KIP2 expression in human esophageal squamous cell carcinoma.
Matsumoto M; Furihata M; Ohtsuki Y; Sasaguri S; Ogoshi S
Anticancer Res; 2000; 20(3B):1947-52. PubMed ID: 10928132
[TBL] [Abstract][Full Text] [Related]
42. Immunoexpression and prognostic role of hTERT and cyclin D1 in urothelial carcinoma.
Yang CH; Hung WC; Wang SL; Kang WY; Chen WT; Huang YC; Su YC; Chai CY
APMIS; 2008 Apr; 116(4):309-16. PubMed ID: 18397466
[TBL] [Abstract][Full Text] [Related]
43. beta-Catenin functions mainly as an adhesion molecule in patients with squamous cell cancer of the head and neck.
Yu Z; Weinberger PM; Provost E; Haffty BG; Sasaki C; Joe J; Camp RL; Rimm DL; Psyrri A
Clin Cancer Res; 2005 Apr; 11(7):2471-7. PubMed ID: 15814622
[TBL] [Abstract][Full Text] [Related]
44. Prognostic significance of biomarkers in squamous cell carcinoma of the tongue: multivariate analysis.
Vora HH; Shah NG; Patel DD; Trivedi TI; Chikhlikar PR
J Surg Oncol; 2003 Jan; 82(1):34-50. PubMed ID: 12501167
[TBL] [Abstract][Full Text] [Related]
45. Prognostic significance of phosphorylated P38 mitogen-activated protein kinase and HER-2 expression in lymph node-positive breast carcinoma.
Esteva FJ; Sahin AA; Smith TL; Yang Y; Pusztai L; Nahta R; Buchholz TA; Buzdar AU; Hortobagyi GN; Bacus SS
Cancer; 2004 Feb; 100(3):499-506. PubMed ID: 14745865
[TBL] [Abstract][Full Text] [Related]
46. Nasopharyngectomy for recurrent nasopharyngeal carcinoma: a review of 31 patients and prognostic factors.
To EW; Lai EC; Cheng JH; Pang PC; Williams MD; Teo PM
Laryngoscope; 2002 Oct; 112(10):1877-82. PubMed ID: 12368634
[TBL] [Abstract][Full Text] [Related]
47. Overexpression of cyclin E messenger ribonucleic acid in nasopharyngeal carcinoma correlates with poor prognosis.
Ko MT; Su CY; Huang SC; Chen CH; Hwang CF
J Laryngol Otol; 2009 Sep; 123(9):1021-6. PubMed ID: 19275777
[TBL] [Abstract][Full Text] [Related]
48. Cyclooxygenase-2 expression in postmastectomy chest wall relapse.
Kim JH; Bossuyt V; Ponn T; Lannin D; Haffty BG
Clin Cancer Res; 2005 Jul; 11(14):5199-205. PubMed ID: 16033837
[TBL] [Abstract][Full Text] [Related]
49. Expression of c-erbB2, cyclin D1 and estrogen receptor and their clinical implications in the invasive ductal carcinoma of the breast.
Lee A; Park WC; Yim HW; Lee MA; Park G; Lee KY
Jpn J Clin Oncol; 2007 Sep; 37(9):708-14. PubMed ID: 17940078
[TBL] [Abstract][Full Text] [Related]
50. Association of cyclin D1 and E1 expression with disease progression and biomarkers in patients with nonmuscle-invasive urothelial cell carcinoma of the bladder.
Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
Urol Oncol; 2007; 25(6):468-75. PubMed ID: 18047954
[TBL] [Abstract][Full Text] [Related]
51. [Effect of hypoxic radiosensitizer sodium glycididazole on long-term result of radiotherapy for nasopharyngeal carcinoma].
Liu MZ; He LR; Lu TX; Chen YY; Hu YH; Cui NJ; Xu GZ; Gao L; Xiao GL; Zhang SW; Cai Y; Li DM; Chen LH; Wang FY; Sun Q; Zhu L; Sheng G; Gao HJ; Bao YH
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):932-7. PubMed ID: 17533747
[TBL] [Abstract][Full Text] [Related]
52. Presence of the latent membrane protein 1 gene in nasopharyngeal swabs from patients with mucosal recurrent nasopharyngeal carcinoma.
Tsang NM; Chuang CC; Tseng CK; Hao SP; Kuo TT; Lin CY; Pai PC
Cancer; 2003 Dec; 98(11):2385-92. PubMed ID: 14635073
[TBL] [Abstract][Full Text] [Related]
53. Detection of local failures after management of nasopharyngeal carcinoma: a prospective, controlled trial.
Ragab SM; Erfan FA; Khalifa MA; Korayem EM; Tawfik HA
J Laryngol Otol; 2008 Nov; 122(11):1230-4. PubMed ID: 18371235
[TBL] [Abstract][Full Text] [Related]
54. Dose escalation for patients with locally advanced nasopharyngeal carcinoma treated with radiotherapy alone.
Yeh SA; Huang YJ
Am J Clin Oncol; 2007 Aug; 30(4):401-5. PubMed ID: 17762441
[TBL] [Abstract][Full Text] [Related]
55. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.
Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K
Hepatogastroenterology; 2003; 50(53):1321-6. PubMed ID: 14571727
[TBL] [Abstract][Full Text] [Related]
56. Expression of cyclin D1 splice variants is differentially associated with outcome in non-small cell lung cancer patients.
Li R; An SJ; Chen ZH; Zhang GC; Zhu JQ; Nie Q; Xie Z; Guo AL; Mok TS; Wu YL
Hum Pathol; 2008 Dec; 39(12):1792-801. PubMed ID: 18715616
[TBL] [Abstract][Full Text] [Related]
57. [Clinicopathologic analysis and expression of cyclin D1 and p53 of ovarian borderline tumors and carcinomas].
Shao HL; Shen DH; Xue WC; Li Y; Yu YZ
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):227-32. PubMed ID: 17631760
[TBL] [Abstract][Full Text] [Related]
58. Management of stage IV glottic carcinoma: therapeutic outcomes.
Spector GJ; Sessions DG; Lenox J; Newland D; Simpson J; Haughey BH
Laryngoscope; 2004 Aug; 114(8):1438-46. PubMed ID: 15280724
[TBL] [Abstract][Full Text] [Related]
59. Cyclin D1 overexpression is a critical event in gallbladder carcinogenesis and independently predicts decreased survival for patients with gallbladder carcinoma.
Hui AM; Li X; Shi YZ; Takayama T; Torzilli G; Makuuchi M
Clin Cancer Res; 2000 Nov; 6(11):4272-7. PubMed ID: 11106243
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of cyclin D1 is associated with poor survival in epithelial ovarian cancer.
Barbieri F; Lorenzi P; Ragni N; Schettini G; Bruzzo C; Pedullà F; Alama A
Oncology; 2004; 66(4):310-5. PubMed ID: 15218299
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
